US Urological Science

Cystoscopy in Haematuria Workup: A Practical Clinical Overview

Haematuria, whether visible or detected on a urine dipstick, prompts a cascade of clinical decisions that often culminates in cystoscopic evaluation. In Australian outpatient clinics, the phrase "blood in the wee" is one patients commonly hear from their GP, and the subsequent pathway through radiology and urology is shaped by local referral networks, Medicare item numbers, and the particular features of the public-private mix of care.

Cystoscopy remains the cornerstone for visualising the bladder and urethra when imaging and laboratory studies raise suspicion of lower urinary tract pathology. While computed tomography urography has largely supplanted intravenous pyelography in the workup of upper tract lesions, the flexible cystoscope gives clinicians a direct view of mucosal abnormalities that scans can miss.

This overview summarises current practice for Australian clinicians managing adult patients with haematuria, with attention to guideline-driven thresholds, procedural nuances, and emerging technologies that may reshape the diagnostic algorithm.

When Cystoscopy Is Indicated in Haematuria

Visible haematuria in an adult over 35, or any episode of frank haematuria regardless of age in the presence of risk factors such as smoking or occupational exposure to aromatic amines, warrants prompt cystoscopic assessment. Dipstick-positive microscopic haematuria in higher-risk cohorts, including those with a family history of urothelial carcinoma or prior pelvic irradiation, also justifies endoscopic evaluation after initial imaging.

In the Australian context, the USANZ-aligned guidelines endorse risk-stratified approaches, and many Sydney and Melbourne teaching hospitals have adopted rapid-access haematuria clinics to streamline triage. A practical threshold used in many of those clinics is three or more red blood cells per high-power field on a properly collected specimen, coupled with persistent positivity on repeat testing.

Not every patient requires the full battery of investigations. Young women with a clear explanation such as a recent urinary tract infection, or men under 40 with transient microscopic haematuria after strenuous exercise, can often be observed after appropriate counselling. The clinical art lies in separating those who need the camera from those who do not.

Flexible Versus Rigid Cystoscopy in the Australian Setting

Flexible cystoscopy, performed under topical urethral lubrication, has become the default diagnostic tool across most Australian centres because it tolerates the awake patient better than the rigid instrument. Rigid cystoscopy under general or spinal anaesthesia retains a role in therapeutic interventions, such as biopsy of suspicious lesions or resection of small tumours, and in patients who cannot tolerate flexible examination.

The choice also depends on equipment availability and theatre scheduling in public hospitals, where waiting lists for general anaesthesia can extend into weeks. Private rooms with flexible scopes can usually accommodate a diagnostic procedure within days, which suits the "see and treat" expectations familiar to many city-based patients. Lidocaine gel preparation is now standard in most public and private suites. For those interested in reviewing a typical instrument workflow, the journal provides a sample-article that walks through a standard diagnostic sequence.

Patient positioning, lubrication protocols, and prophylactic antibiotic use vary between institutions, but a lidocaine gel preparation is now standard in most public and private suites. Documenting the indication clearly remains essential for audit and billing purposes, particularly when the indication falls outside the standard MBS descriptors.

Australian Clinical Guidelines and Reimbursement

The Medicare Benefits Schedule funds cystoscopy under specific item numbers for diagnostic and therapeutic indications, and Australian clinicians familiarise themselves with the criteria for claiming item numbers such as 36836 for flexible cystoscopy. Public hospital outpatient clinics absorb the cost for public patients, while private patients typically receive a rebate that depends on their insurer's gap arrangements.

Guidelines published by the Urological Society of Australia and New Zealand, alongside contributions from ANZUP, provide consensus thresholds for when to image, when to scope, and when to discharge. Telehealth follow-up, accelerated by pandemic-era reforms, has made it easier for regional patients in places like Tamworth or Cairns to discuss results with their urologist without travelling to Brisbane or Sydney.

Practitioners should document the indication clearly, particularly when the indication falls outside the standard MBS descriptors, as audits have flagged this as a recurring compliance issue. Engaging practice managers and billing staff in regular education sessions reduces the risk of rejected claims and supports defensible clinical practice.

Patient Preparation and Procedural Consent

Explaining the procedure in plain language reduces anxiety and improves cooperation, and Australian patients often respond well to a stepwise walk-through of what they will feel. Phrases such as "a bit of pressure when the camera goes past the prostate" or "you'll feel like you need to pass urine" demystify the experience for those who have never had an endoscopic procedure.

Written consent should cover bleeding, infection, urethral stricture, and the small risk of perforation, and patients should be counselled about warning signs after discharge. A contact number for after-hours advice is standard, and a brief phone check the next arvo helps catch early problems and reassures anxious patients.

For patients with bleeding disorders or on anticoagulation, planning with the haematology team or the patient's cardiologist is essential, and the procedure should not be delayed unnecessarily in those with visible haematuria and clots. Clear instructions about driving, work, and sexual activity after rigid cystoscopy should be provided in both verbal and written form.

Interpreting Findings and Risk Stratification

Cystoscopic findings range from innocent vascular malformations and chronic inflammatory changes to papillary tumours and flat carcinoma in situ. Documenting the location, size, number, and appearance of lesions using a standardised proforma improves communication with the multidisciplinary team and supports structured follow-up.

Risk stratification tools such as the EAU risk groups for non-muscle-invasive bladder cancer help guide the intensity of adjuvant therapy and surveillance. Patients with low-risk Ta lesions may be candidates for office-based fulguration and early discharge, while those with high-grade or T1 disease require formal resection under anaesthesia.

Referencing comparative procedural data, the journal's coverage of comparing open and laparoscopic techniques for partial nephrectomy illustrates how surgical decision-making has evolved across urological subspecialties, and the same principles of weighing morbidity against oncological benefit apply to bladder tumour management.

Managing Complications and Post-Procedure Care

Post-procedure urinary symptoms such as frequency, urgency, and mild dysuria are common and usually settle within 48 hours. Significant bleeding, fever, or inability to void warrants urgent review, and patients should have a clear pathway back to the treating team or the local emergency department.

Urosepsis, though uncommon after diagnostic cystoscopy, remains the most feared complication, and adherence to sterile technique and judicious prophylactic antibiotics reduces its incidence. Patients with indwelling catheters left after therapeutic procedures need clear catheter-care instructions and a date for removal.

For paediatric and adolescent patients, differential diagnosis of haematuria differs markedly, and clinicians occasionally encounter co-existing conditions such as inguinal hernias requiring paediatric surgical input; parents seeking information on that topic may consult pediatric hernia resources for broader context. While cystoscopy is rarely indicated in children with microscopic haematuria alone, the threshold for endoscopic evaluation should be lower in those with visible bleeding or associated structural anomalies.

New Frontiers: Imaging and Biomarkers

Photodynamic diagnosis using hexaminolevulinate and narrow-band imaging have improved detection rates for flat lesions, and several Australian centres now routinely employ these adjuncts during TURBT. The evidence base continues to grow, with meta-analyses suggesting meaningful gains in tumour detection that translate into lower recurrence rates.

Urinary biomarkers such as UroVysion, NMP22, and bladder tumour antigen offer potential for surveillance rather than primary detection, and their role in the Australian algorithm is still being defined through ANZUP-led trials. Multiparametric MRI of the bladder remains experimental in most centres but holds promise for staging and treatment planning.

As clinical pathways become more nuanced, the balance of probabilities will continue to influence decision-making, and clinicians often find themselves weighing options in much the way a player evaluates strategic odds before committing resources. Shared decision-making with well-informed patients remains the foundation of good care.

Practical Recommendations for Australian Clinicians

For ongoing professional development, explore the latest research, submit your own work, and consider subscribing to receive table-of-contents alerts that match your subspecialty interests—your engagement drives the quality of care for the next Australian patient who notices blood in their urine.